Literature DB >> 16553098

Colorectal cancer screening: today and tomorrow.

Kenneth E Hung1, Daniel C Chung.   

Abstract

Colorectal cancer remains a disease with significant morbidity and mortality. However, the prognosis can be greatly improved with early detection. Here, we review the current screening modalities and guidelines for patients at average, moderate, and high risk for colorectal cancer. New experimental modalities are also introduced.

Entities:  

Mesh:

Year:  2006        PMID: 16553098     DOI: 10.1097/01.smj.0000203817.89741.29

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  A pilot study of gas chromatograph/mass spectrometry-based serum metabolic profiling of colorectal cancer after operation.

Authors:  Yanlei Ma; Weijie Liu; Jiayuan Peng; Long Huang; Peng Zhang; Xiaoping Zhao; Yiyu Cheng; Huanlong Qin
Journal:  Mol Biol Rep       Date:  2009-04-02       Impact factor: 2.316

2.  Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer.

Authors:  Yan-Lei Ma; Huan-Long Qin; Wei-Jie Liu; Jia-Yuan Peng; Long Huang; Xiao-Ping Zhao; Yi-Yu Cheng
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

3.  Methylation pattern of SFRP1 promoter in stool sample is a potential marker for early detection of colorectal cancer.

Authors:  R Salehi; M Mohammadi; M H Emami; A R Salehi
Journal:  Adv Biomed Res       Date:  2012-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.